The realm of medical news publications is not without its fair share of controversy. Recently, the New England Journal of Medicine came under fire for cutting off certain publications from advanced access to its embargoed journal articles. This decision was met with criticism from experts like Ivan Oransky, MD, who likened it to a ‘don’t
Health
In our society, where bad news dominates the media, important trends sometimes get lost in the noise. One such trend is the increasing cases of abuse and neglect of dependent individuals. Negligent care of a dependent person refers to the criminal offense of neglecting a “care-dependent person” by a caretaker. This includes failing to provide
The New England Journal of Medicine (NEJM) recently announced a significant change in its access policy regarding embargoed journal articles. According to Dawn Peters, director of strategic communications & media relations at NEJM Group, news outlets targeting physician readers will no longer qualify for embargoed access. This decision has implications for reporters who apply to
A recent phase IIb PARADIGM trial has shown promising results for a novel treatment candidate for amyotrophic lateral sclerosis (ALS). The treatment, known as PrimeC, is a combination of two FDA-approved drugs, ciprofloxacin, and celecoxib. The trial, presented at the American Academy of Neurology annual meeting by Merit Cudkowicz, MD, MSc, of Massachusetts General Hospital,
Antipsychotic drugs are commonly prescribed to patients with dementia to manage behavioral and psychological symptoms. However, a recent population-based matched cohort study from the U.K. has shed light on the increased risk of adverse outcomes associated with the use of antipsychotics in dementia patients. The study analyzed data from over 170,000 adults with dementia and
Duchenne muscular dystrophy (DMD) is a devastating genetic disorder primarily affecting boys, characterized by mutations in the dystrophin gene leading to muscle damage and weakness. Recently, Viltolarsen, also known as Viltepso, has shown promise as a potential treatment for DMD through exon-skipping therapy. The open-label, phase II Galactic53 trial revealed intriguing results regarding the safety
Recently, there have been several disturbing cases in the medical field that have garnered attention. An anesthesiologist in Dallas was convicted for injecting dangerous substances into IV bags, leading to a tragic death and multiple cardiac emergencies. Additionally, two doctors from Ohio and Kentucky were sentenced to prison time and fined for their involvement in
Accessing newer, highly effective cholesterol-lowering drugs remains a challenge in the medical field, as highlighted by Christie Ballantyne, MD, of Baylor College of Medicine in Houston. Despite some improvements, the prior authorization burden continues to be a pain point for healthcare providers. This issue points to the need for streamlining the process to ensure that
It is not every day that a healthy 28-year-old woman presents with a gradually expanding mass in the inside corner of her left eye, prompting clinicians to investigate the root cause. This particular patient had been on a humanitarian mission in the Democratic Republic of Congo and reported the appearance of a lump 2 years
Republican lawmakers have criticized FDA Commissioner Robert Califf, MD, for the agency’s handling of issues such as the authorization of COVID-19 vaccines and the negative campaign against ivermectin. Rep. Paul Gosar raised concerns over the emergency use authorization of COVID-19 vaccines, claiming that they do not stop virus transmission and have been linked to injuries